Xlife Sciences Aktie
WKN DE: A2PK6Z / ISIN: CH0461929603
03.09.2024 07:00:20
|
Xlife Sciences AG Completes Strategic Review Process by Q3 2024
Xlife Sciences AG / Key word(s): Miscellaneous Zurich, 3rd of September 2024: Xlife Sciences AG (SIX: XLS) today announced that the Board of Directors has completed the strategic review and, as of September 2, 2024, has tasked management with implementing the process. The shareholders will be informed of the next steps by September 30, 2024, at the latest. The size and diversity of the portfolio, along with the variety of possible deal structures, significantly influenced the timeline of the process. Xlife Sciences AG extends its gratitude to all external partners for their support and valuable contributions to this important milestone. David L. Deck, Chairman of the Board of Directors of Xlife Sciences AG, commented: «The strategy identified as a result of intensive analysis and consultations represents the best option to ensure the company's long-term success and value creation. The Board is confident that this path offers the greatest potential for the future of Xlife Sciences.»
Financial calendar
Contact Xlife Sciences AG, End of Inside Information |
Language: | English |
Company: | Xlife Sciences AG |
Talacker 35 | |
8001 Zürich | |
Switzerland | |
Phone: | +41 44 385 84 60 |
E-mail: | info@xlifesciences.ch |
Internet: | www.xlifesciences.ch |
ISIN: | CH0461929603 |
Valor: | A2PK6Z |
Listed: | SIX Swiss Exchange |
EQS News ID: | 1980087 |
End of Announcement | EQS News Service |
|
1980087 03-Sep-2024 CET/CEST

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Xlife Sciences AGmehr Nachrichten
01.04.25 |
Optimismus in Zürich: SPI liegt am Nachmittag im Plus (finanzen.at) | |
01.04.25 |
Gewinne in Zürich: So entwickelt sich der SPI am Dienstagmittag (finanzen.at) | |
31.03.25 |
Verluste in Zürich: SPI zeigt sich am Montagnachmittag leichter (finanzen.at) | |
28.03.25 |
SPI-Wert Xlife Sciences-Aktie: So viel hätten Anleger mit einem Investment in Xlife Sciences von vor 3 Jahren verloren (finanzen.at) | |
27.03.25 |
Schwacher Handel: SPI notiert zum Start im Minus (finanzen.at) | |
26.03.25 |
SPI-Handel aktuell: So steht der SPI aktuell (finanzen.at) | |
26.03.25 |
Börse Zürich in Rot: SPI zum Start des Mittwochshandels in der Verlustzone (finanzen.at) | |
25.03.25 |
Optimismus in Zürich: SPI bewegt sich zum Handelsstart im Plus (finanzen.at) |
Analysen zu Xlife Sciences AGmehr Analysen
Aktien in diesem Artikel
Xlife Sciences AG | 22,70 | -2,58% |
|